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Background: Plasmodium vivax reticulocyte binding protein-2 (PvRBP-2) is a promising candidate for development
of vaccine against parasite. DNA sequence polymorphism in pvrbp-2 which may hamper the vaccine development
program has been identified in laboratory strains. Therefore, unraveling genetic polymorphism in pvrbp-2 from field
isolates is a prerequisite for success in vaccine development. This study was designed with a primary aim to
uncover genetic polymorphism in pvrbp-2 among P. vivax field isolates.
Results: Using virtual restriction mapping of pvrbp-2 sequences, two restriction enzymes (AluI and ApoI) were
selected for the development of pvrbp-2 as a PCR-RFLP marker. Restriction fragment length polymorphism (RFLP)
analysis revealed a high degree of genetic polymorphism in the pvrbp-2 gene among field isolates of P. vivax.
ApoI-RFLP was found to be more efficient in identifying the extent of genetic polymorphism in pvrbp-2 compared
to AluI-RFLP. Combined genotyping/haplotyping of RFLP pattern revealed a total of 36 distinct RFLP patterns
among 83 P. vivax isolates analyzed. DNA sequence analysis also supports high degree of genetic polymorphism
among field isolates of P. vivax. Pvrbp-2 PCR-RFLP method is able to distinguish multiple infection up to 16.86%
and it revealed a low level of shared genetic pool between more than two populations.
Conclusion: The study suggests that pvrbp-2 is highly polymorphic genetic marker which can be used for
population genetic analyses. RFLP analysis suggests presence of nearly similar proportion of Sal-1 and Belem alleles
in Indian P. vivax populations. The larger extent of genetic polymorphism identified from limited samples advocates
to screen genetic polymorphism in pvrbp-2 from malaria endemic geographical regions and countries for designing
pvrbp-2 based anti-malarial control measures.Background
Plasmodium vivax is the most widely distributed human
malaria parasite outside sub Sahara regions of Africa.
Although mild with its prolonged and recurrent infec-
tion resulting in huge morbidity, the species can also
be severe and fatal [1-6]. Annual burden is estimated to
be about 70–80 million cases globally [7], however
in India, P. vivax is responsible for about one million
malaria cases annually, contributing 50–55% of total
malaria cases.
Using molecular techniques, genetic diversity studies
of malaria parasites accelerated substantially and pro-
vided a landmark in understanding parasite genetic
diversity, evolution of pathogenicity and drug resistance,
and transmission success. Identifying highly polymorphic* Correspondence: surendramrc@gmail.com
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reproduction in any medium, provided the ormarker is essential for studying genetic diversity, popula-
tion structure, multiplicity of infection, and relapse and
recrudescence infection etc. Till date, two types of
molecular markers are in frequent use to unraveled gen-
etic diversity from field isolates of P. vivax, these are
tandem repeats markers [8,9] and antigen encoding
genes [10-12].
Invasion of erythrocytes by malaria parasite is a complex
and multi-step process. Merozoites of P. vivax primarily in-
vade the reticulocytes [13] whereas P. falciparum can in-
vade both mature RBC as well as reticulocytes [14,15]. The
specificity in binding with reticulocytes is mediated by a set
of proteins which are encoded by a gene family called
reticulocyte binding protein where members of this family
are found in malaria parasites of human, simian and ro-
dent [16-19]. The major function of reticulocyte bind-
ing protein is seen during the initial steps of erythrocyte
selection and invasion [17]. Evidence suggests that thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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zoite and confer the reticulocyte-specificity of P. vivax
blood-stage infections, suggesting the essential role of
RBP-II in selection and identification of reticulocyte for
invasion [17]. Two pvrbp-2 genes have been character-
ized from P. vivax and are shown to be a promising
vaccine candidate [20]; however, up to 12 putative
pvrbp genes have been identified in P. vivax genome so
far [21].
Pvrbp-2 is a promising vaccine target for the develop-
ment of effective anti-malarial control measures [20].
However, genetic polymorphism at pvrbp-2 may hamper
the efficacy of vaccine [22]. Therefore, investigation
of genetic polymorphism at pvrbp-2 from geographical
field isolates is an essential step. This study was designed
to investigate the genetic polymorphism in pvrbp-2




This study was approved by the Ethics Committee of the
National Institute of Malaria Research and all blood
spots were collected with written consent of the patients
and/or their legal guardians.
Parasite collection and DNA extraction
Ninety P. vivax field isolates collected between 2003–
2006 from six geographical regions of the Indian sub-
continent were analyzed (Figure 1). Finger prick blood
from the symptomatic patients in active case detection
surveys as well as from patient attending the clinics, was
spotted on autoclaved Whatman filter paper strips
(Number 3). The six geographical regions are Delhi
(N=13), Nadiad of Gujarat (N=26), Panna of Madhya
Pradesh (N=18), Rourkela of Odisa (N=16), Chennai of
Tamil Nadu (N=10), and Kamrup of Assam (N=7).
Details of individual study sites such as location, parasite
and vector species prevalence, and disease transmission
pattern are reported elsewhere [23] as well as given in
Additional file 1. Genomic DNA was isolated from
microscopically diagnosed vivax-positive blood spotted
on Whatman filter paper (3 mm) strips using QIAamp
mini DNA kit (Qiagen, Germany). Three punches
(5 mm diameter) of dried blood spots were used for
DNA isolation, as per the manufacturer’s instructions.
DNA was eluted in 120 μl triple distilled autoclaved
water and stored at −20°C for future use.
Primer designing and PCR amplification
Nested PCR primers for pvrbp-2 gene were designed
manually using pvrbp-2 sequence available in GenBank
(AY501887). These primers are RBP2-F (5’-gatgatcaatttt-
tatgcctgac-3’), RBP2-R (5’-cagaatccgcaataatagag-3’), RBP2-NF (5’-ttcccgcacacacaaggtag-3’), RBP2-NR (5’-gcgtagtgtt-
tagctgccac-3’), RBP2-IR1 (5’-tggaaccgtatgcgattc-3’) and
RBP2-IR2 (5’-ttttgcagataagatagc-3’). Internal primers used
for sequencing this fragment are IR1 and IR2 and the
schematic diagram of gene showing location of primers is
given in Figure 2. Optimized PCR conditions for primary
PCR for amplification of pvrbp-2 were:-initial denatur-
ation 95°C/5 minute, denaturation 95°C/30 S annealing
50°C/30 S and extension at 68°C/2 minute for 35 cycles,
and a final extension of 68°C/5 minute. The cycling
conditions of nested PCR were similar to primary PCR
except annealing temperature, which was 55°C. All PCR
amplifications were carried out in a 20 μl reactions vol-
ume (Qiagen’s Master Mix) with 10 pM of each primer
and.1-2 μl (~ 3–5 ng) of genomic DNA in primary PCR
and 0.5-1 μl of primary PCR product in nested PCR.Restriction Fragment Length Polymorphism (RFLP)
To determine the level of pvrbp-2 polymorphism, RFLP
analysis was carried out using two restriction enzymes
ApoI and AluI (NEB Inc, USA). These enzymes were
selected on the basis of maximum probability of
enzymes cutting sites in the polymorphic region of
pvrbp-2 and the feasibility to resolve digested PCR frag-
ment on agarose gel. Virtual restriction mapping of
pvrbp-2 was done using SeqBuilder module of DNA
Lasergene 7.1 software for identification of suitable
restriction enzymes for RFLP study. Four microliters
of PCR product was digested with individual restriction
enzyme. AluI digestion was incubated at 37°C for 4 hours
whereas ApoI was incubated at 50°C for overnight. In
both digestions, heat inactivation for enzymes was given
at 80°C/20 minutes. The restriction products were visua-
lized on a 2.5 % agarose gel containing ethidium brom-
ide. A consistent current at 0.75 m for 2.5 hrs were used
for all agarose gel electrophoresis experiments to achieve
consistency in RFLP fragment sizes.RFLP Genotyping and multiple infection typing
Digested DNA fragments were assessed using Genetool
software and all fragments were considered for genotyp-
ing of RFLP data. In RFLP analysis, the restriction pat-
tern of each enzyme was typed where each different/
unique RFLP pattern was assigned 1. . .n as an allele.
Finally, RFLP patterns of ApoI and AluI from each
sample were combined to make a “haplotype or geno-
type”. This “haplotyping/ genotyping” method provides a
high-resolution power for differentiating parasites com-
pared with RFLP pattern of individual enzyme.
Multiple infection could only be detected by RFLP
analysis since all samples show only a single PCR
fragment. A sample was considered as multi-clone infec-
tion if the sum of the digested fragments (either ApoI
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Figure 1 Map of India showing study sites. N indicates number of sample from individual geographical region.
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PCR fragment.
Cloning, DNA sequencing, and sequence analysis
DNA sequencing of limited samples was done in order
to validate RFLP pattern as well as to differentiate Sal-1
and Belem alleles of pvrbp-2. PCR products from 13
samples (Nadiad; 7, Delhi; 1, Kamrup; 2, and Panna;
3) were purified using gel extraction kit (MDI, India)
and cloned in pTZ257R/T vector (Fermentas, USA). Six
of 13 samples were single clone in nature on the basis of
pvrbp-2 RFLP analysis. Plasmid was purified using plas-
mid extraction kits (MDI, India) and purified plasmids
were sequenced commercially (Macrogen Inc, Seoul,
Korea) [24]. For DNA sequencing, each plasmid was
sequenced with forward, reverse and internal primers.1 2315 
F 
NF NR 
R IR2 IR1 
Figure 2 Diagrammatic representation of primers location on pvrbp-2
and arrows indicate location of primers. F and R: forward and reverse prim
primers of nested PCR respectively. IR1 and IR2 are internal sequencing primDNA Lasergene software 7.1 (DNA Star Inc., USA)
was used for editing raw DNA sequences (EditSeq module),
with SeqMan module used for contig formation and
ClustalW module for sequences alignment. DNA sequences
of pvrbp-2 obtained from field isolates of P. vivax were
deposited in GenBank (JN872360-JN872372).
Results
Identification of genetic polymorphism using
PCR-RFLP method
A total of 90 P. vivax samples were analyzed where in
all samples gave single clear amplification of ~2.0 kb
fragment size and none of the PCR fragments showed
size variation (Figure 3a). Amplified PCR fragment
covers both coding and non-coding regions. The coding
regions are marked by a 449–503 bp and 705–1946 bp9901
gene. Gray and black boxes indicate intron and exon respectively,
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Figure 3 Gel pictures of PCR and RFLP of pvrbp-2 gene, a) PCR amplification, b) AluI digestion, c) ApoI digestion. Name above the each
well represents sample identity.
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tion mapping of pvrbp-2 sequence suggests the use of
ApoI and AluI restriction enzymes for RFLP analysis.
Initially, five samples were digested with the above two
enzymes to make sure that these enzymes can identify
genetic polymorphism from field isolates. Interestingly,
genetic polymorphism in AluI and ApoI digestion was
observed in selected five samples. Further, PCR products
obtained from 83 P. vivax isolates were digested with
AluI and ApoI enzymes separately. RFLP pattern of
pvrbp-2 gene with AluI and ApoI has been shown in
figure 3b & c respectively.
A substantial number of RFLP pattern for both
enzymes were observed with respect to the Sal-1 strain
based pvrbp-2 gene sequence. In total, 13 distinct AluI
and 30 distinct ApoI RFLP patterns were observed
among 83 samples. RFLP analysis revealed mainly two
distinct digestion patterns in field isolates by both
enzymes. This suggests that each enzyme has two major
types of digestion pattern. RFLP pattern of six samples
was confirmed by DNA sequencing. Among six samples,
DNA sequences of five samples were in agreement with
RFLP data, however in a single sample (Pv-7) RFLP pat-
tern of only ApoI enzyme was not matched. This may be
due to the sequencing of only one clone from each clon-
ing experiment. The numbers of RFLP pattern of indi-
vidual enzymes from all samples are listed in Table 1.
The frequencies of AluI and ApoI genotypes varied in
field isolates (Figure 4). Further, combination of AluI
and ApoI RFLP patterns revealed a total of 36 distinct
haplotypes/genotypes suggesting a high degree of genetic
diversity in pvrbp-2 sequences in the field isolates of P.
vivax.
Multiple infection and population genetic structure
In brief, if a mono-infection sample (infection of single
species) show a single genotype, it is denoted as single-clone infection, but if it shows more than one genotype,
it is denoted as a multi-clone/multiple infection. RFLP
analysis using AluI, showed seven isolates (8.43%) to
have multi-clone infection. In contrast, ApoI showed 13
isolates (15.66%) as multi-clone infection. In total, 14
isolates (16.86%) were observed to have multi-clone
infection. Four multi-clone samples were having both
Sal-1 and Belem alleles, however remaining ten multi-
clone isolates were infected with different genotypes of
either Sal-1 or Belem alleles.
Genetic polymorphism was observed among all geo-
graphical regions of the Indian subcontinent. The total
number of genotypes observed in Delhi, Nadiad, Panna,
Rourkela, Chennai and Kamrup were 11, 14, 12, 7, 7 and
4 respectively. In every geographical region, genotypes
were observed to be unique (local polymorphism) and
shared in varied proportion (Figure 5). Allelic analysis
shows a limited fraction of genotypes were observed to
have been shared within 2–3 populations. Only a single
genotype (14) was observed in five geographical regions,
however, none of the shared genotypes was observed
between six geographical regions. This study suggests a
diverse pool of pvrbp-2 repertoire in all geographical
regions. This study also uncovered many unique pvrbp-2
genotypes to exist among geographical regions.
DNA sequence polymorphism
To understand and support the high degree of genetic
diversity observed in PCR-RFLP analysis in pvrbp-2, 13
random samples (Nadiad; 7, Delhi; 1, Kamrup; 2, and
Panna; 3) were sequenced, of which six isolates were
RFLP analyzed. DNA sequence analysis also revealed a
high degree of genetic polymorphism such as indels/tan-
dem repeats and single nucleotide polymorphism (SNPs)
among field isolates of P. vivax. Two indels were found
which were restricted to non-coding region. The tandem
repeat consisted of six amino acids (PA/TT/VQKK)
Table 1 RFLP data and genotyping of Plasmodium vivax using pvrbp-2 gene






ApoI RFLP Pattern (bp)
Pv-2 1200 410 280 90 1 1/8 1 650 450 180 170 160 140 120 80
Pv-7 1200 430 280 90 2 2/2 2 650 180 170 160 130 120
Pv-14 1500 1200 410 380 280 3 3/1 3 800 650 450 410 250 180 120
ND-52 1500 380 80 4 4/2 4 800 410 250 180 120 90
ND-51 1200 430 280 90 2 5/5 5 650 480 180 170 160 140 130 120
ND-54 1200 410 280 180 90 5 6/1 6 650 450 180 170 160 140 130 120
M-53 1500 380 6 7/3 7 800 410 250 180 120
M-54 1200 430 380 90 7 8/1 7 800 410 250 180 120
M-55 1200 430 280 90 2 9/1 8 850 800 750 180 170 120 80
ND-57 1000 430 280 180 90 8 10/2 9 800 650 180 170 120
RR-1 1200 430 280 90 2 11/2 10 800 480 180 170 140 120 80
RR-18 1200 430 380 80 7 12/1 11 650 450 250 180 160 120 90
M-51 1200 430 280 90 2 13/1 12 650 180 170 160 130 120 80
M-57 1200 410 280 90 1 14/2 13 800 480 180 170 140 120
M-58 1500 380 6 15/10 14 800 410 250 180 120 80
M-59 1200 410 280 90 1 16/4 15 650 450 180 170 160 140 120
ND-1 1200 430 280 90 2 17/3 16 650 480 180 170 160 140 120
ND-2 1200 430 280 90 2 18/1 13 800 480 180 170 140 120
ND-8 1200 430 280 90 2 19/1 17 650 180 170 160 120
ND-12 1200 430 280 90 2 20/1 18 800 650 180 170 130 120
ND-14 1200 430 410 280 90 9 21/1 19 800 650 450 180 170 140 130 120
ND-29 1500 380 80 4 22/10 14 800 410 250 180 120 80
P-5 1500 380 80 4 23/1 21 650 410 250 180 160 120 80
R-12 1200 410 280 90 1 24/2 22 650 600 180 170 160 120
R-18 1200 430 280 90 2 25/2 23 800 480 180 170 140 130 120
A-385 1500 1200 430 380 280 10 26/1 24 800 650 410 250 180 170 120
R-37 1200 430 280 90 2 27/1 25 800 650 480 180 170 120
D1 1200 410 280 90 1 28/2 6 650 450 180 170 160 140 130 120
D5 1200 430 280 90 2 29/2 26 650 600 180 170 160 130 120
S2 1500 380 6 30/2 27 800 650 250 180 120
S4 1200 430 280 90 2 31/1 28 650 450 180 170 160 140 130 120
C1 1200 410 280 90 1 32/1 29 600 180 170 160 130 120
C2 1200 410 280 90 1 33/1 28 600 450 180 170 160 140 130 120
C5 1200 430 380 11 34/1 30 800 450 250 180 120 80
C6 1500 1200 430 410 280 12 35/2 3 800 650 450 410 250 180 120 80
C8 1200 400 380 13 36/1 14 800 410 250 180 120 80
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SNPs were found, out of which 32 were in non-coding
region while the remaining were in coding region. The
observed higher number of SNPs was mainly due to the
dimorphism between Sal-1 and Belem type alleles. Num-
ber of non-synonymous substitutions in coding region
was higher (n=106) as compared to synonymoussubstitutions (n=46), which indicates that pvrbp-2 is
under positive selection pressure. None of the SNP (syn-
onymous or non synonymous) was associated with
frame shift mutation. Comparison of pvrbp-2 sequences
from Indian field isolates with pvrbp-2 reference
sequence (Sal-1: P. vivax strain) suggests a higher de-
gree of DNA sequence polymorphism.
Figure 4 Distribution of AluI and ApoI RFLP genotypes among Indian field isolates of Plasmodium vivax.
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The virtual restriction mapping of pvrbp-2 sequences
AluI and ApoI enzymes reveals a distinct RFLP pattern
of Belem and Sal-1 alleles. Virtual restriction mapping
of pvrbp-2 with AluI revealed a distinct 1500 bp and
380 bp fragments for Belem allele. Similarly, virtual
restriction mapping with ApoI showed a distinct 250 bp
fragment for Belem allele. The results of virtual restric-
tion mapping of Belem and Sal-1 pvrbp-2 sequences
with AluI and ApoI enzymes were confirmed with RFLP
analysis of field isolates. On the basis of RFLP patterns,
all samples were categorized according to the Sal-1 and
Belem type. Of the 83 P. vivax isolates analyzed, 38.55%
(32/83) were Belem type, 56.63% (47/83) were Sal-1 type,
and 4.82% (4/83) were mixed of both alleles (Table 2).
Furthermore, comparison of RFLP pattern showed Sal-1
alleles to be more polymorphic (24/36) than Belem al-
lele (12/36) in the natural parasite populations. Thus,
dimorphism observed in sequence analysis could also be
identified by simple PCR-RFLP method.Figure 5 Number of unique and shared pvrbp-2 genotypes among stDiscussion
Malaria eradication program is facing remarkable chal-
lenges due to spread of drug resistance and the complex
population genetic structure of human malaria parasites.
Gaining an insight into the genetic population structure
of the parasites would provide valuable information for
designing an improved malaria control strategy. The
present study investigates genetic polymorphism in
pvrbp-2 among field isolates of P. vivax using simple
PCR-RFLP.
This is the first population based study of pvrbp-2
gene which revealed a high degree of polymorphism in
field isolates of P. vivax. The sequence polymorphism
reported in pvrbp-2 from four strains of P. vivax includ-
ing Sal-1 and Belem [22] is supporting the extent of
genetic polymorphism observed in pvrbp-2 in Indian iso-
lates. The sequences of pvrbp-2 have shown a distinct
dimorphism between Sal-1 and Belem alleles [22]. The
dimorphism between Sal-1 and Belem strains of P. vivax
has been reported earlier on the basis of pvmsp-1 [25]udy sites.
Table 2 Distribution of Pvrbp-2 based Sal-1 and Belem






Delhi 13 8 5
Nadiad 21 17 4
Panna 18 7 11
Rourkela 16 10 4 2
Chennai 10 3 5 2
Kamrup 5 2 3
Total (n) 83 47 32 4
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entirely based on geographical location and allelic vari-
ation. The RFLP analysis of the present study using AluI
and ApoI enzymes revealed a high degree of genetic
polymorphism among field isolates which was further
supported by pvrbp-2 nucleotide sequence polymorph-
ism data. From RFLP analysis, it is clear that ApoI is
identifying larger extent of genetic polymorphism in field
isolates compared to AluI. This suggests that under lim-
ited resources, ApoI alone can be used to resolved larger
extent of existing genetic variation in pvrbp-2 in the field
isolates. The genetic polymorphism displayed by various
antigen-encoding genes and biochemical marker in In-
dian field isolates of P. vivax [26-32] is also supported
by the genetic polymorphism observed in pvrbp-2.
Plasmodium vivax isolates from Indian subcontinent
represents diverse pool of genetic variants such as Belem
and Chesson alleles in pvgam-1 [23], Belem and Sal-1
alleles in pvmsp-1 [30], and VK210 and VK247 in pvcsp
[30]. Though, pvrbp-2 based Sal-1 and Belem alleles
have not been identified from natural parasite popula-
tions, however present study uncovered both alleles in
Indian P. vivax populations. As like other above genetic
markers, pvrbp-2 also harbors both Sal-1 and Belem
alleles in Indian populations however, their proportion
varied between geographical regions.
Pvrbp-2 is a promising vaccine target for the develop-
ment of effective anti-malarial control measure [20].
Identifying allelic polymorphism in pvrbp-2 within and be-
tween populations would certainly improve and extend
the existing knowledge for development of anti-malaria
control measure. The significance of this prospective
study would be to uncover maximum number of hidden
polymorphism. Several studies in recent past have
shown many polymorphic forms in local population
[10,12,31,33]. This study revealed genetic polymorph-
ism in P. vivax populations which have been rarely
shared between more than two populations which sug-
gests that in the natural population, pvrbp-2 is diverse
and this calls for thorough care to be taken while
designing any anti-malarial strategy targeting pvrbp-2.Conclusions
The study suggests that pvrbp-2 is highly polymorphic
genetic marker which can be used for population genetic
analyses. RFLP analysis suggests presence of nearly
similar proportion of Sal-1 and Belem alleles in Indian
P. vivax populations. The larger extent of genetic poly-
morphism identified from limited samples advocates to
screen genetic polymorphism in pvrbp-2 from malaria
endemic geographical regions and countries for design-
ing pvrbp-2 based anti-malarial control measures.
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